3//SEC Filing
Eilean Therapeutics, LLC 3
Accession 0001213900-24-094662
CIK 0001900520other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 5:57 PM ET
Size
4.8 KB
Accession
0001213900-24-094662
Insider Transaction Report
Form 3
Eilean Therapeutics, LLC
10% Owner
Holdings
- 14,420,383
Common Stock
Footnotes (1)
- [F1]On November 1, 2024, the Issuer closed the transactions contemplated by the Agreement and Plan of Merger and Reorganization (the "Merger Agreement"), dated as of November 1, 2024, by and among Venetian-1 Acquisition Corp., a Delaware corporation (the "Parent"), Lomond Acquisition Corp., a Delaware corporation (the "Acquisition Subsidiary"), and Lomond Therapeutics, Inc. ("Legacy Lomond") (the "Merger"), pursuant to which, upon consummation of the Merger, all of the outstanding shares Legacy Lomond common stock were converted into shares of the Issuer's Common Stock on a 1:1 basis pursuant to the terms of the Merger Agreement (the "Merger").
Documents
Issuer
Lomond Therapeutics Holdings, Inc.
CIK 0001900520
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002042386
Filing Metadata
- Form type
- 3
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 5:57 PM ET
- Size
- 4.8 KB